Jones JA, Mato AR, Wierda WG. et al. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol 2018; 19: 65-75
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.